| Lotus Noire Health | |
|
400 Warren Ave Ste 2l-a East Providence RI 02914-3826 | |
| (401) 305-0080 | |
| (866) 655-0696 |
| Full Name | Lotus Noire Health |
|---|---|
| Speciality | Nurse Practitioner |
| Location | 400 Warren Ave Ste 2l-a, East Providence, Rhode Island |
| Authorized Official Name and Position | Temperance Taylor (OWNER) |
| Authorized Official Contact | 4013050080 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Lotus Noire Health 400 Warren Ave Ste 2l-a East Providence RI 02914-3826 Ph: (401) 305-0080 | Lotus Noire Health 400 Warren Ave Ste 2l-a East Providence RI 02914-3826 Ph: (401) 305-0080 |
| NPI Number | 1164040069 |
|---|---|
| Provider Enumeration Date | 07/08/2020 |
| Last Update Date | 09/03/2023 |
| Certification Date | 09/03/2023 |
| Medicare PECOS PAC ID | 0244645620 |
|---|---|
| Medicare Enrollment ID | O20210217000570 |
News Archive
Scratching the skin triggers a series of immune responses culminating in an increased number of activated mast cells-immune cells involved in allergic reactions-in the small intestine, according to research conducted in mice.
The Medical University of South Carolina (MUSC), one of the nation's top academic health science centers, and Alliance Oncology, a division of Alliance HealthCare Services, Inc., announce a newly formed affiliation designed to strengthen and expand MUSC's Hollings Cancer Center as the radiation therapy market leader in Charleston, South Carolina.
In the study, which appeared on the pre-print server medRxiv, the team developed a general mathematical theory to predict airborne transmission risk from carbon dioxide (CO2) time series in real-time and clarify different estimates that steer the guideline. The study findings were based on the assessment of transmission risk and implementing the guideline by CO2 monitoring in university classrooms and office spaces.
YM BioSciences Inc. has announced data from two clinical trials of nimotuzumab, its humanized monoclonal antibody that targets the epidermal growth factor receptor (EGFR). Preliminary results from the two trials which are evaluating nimotuzumab in combination with radiation therapy for the treatment of brain metastases and high-grade gliomas, conducted by YM's licensor, were presented at the 2008 EORTC-NCI-AACR annual meeting recently held in Geneva, Switzerland.
A new survey has discovered the quite astonishing fact that almost half of American adults mistakenly believe that surgery can spread cancer, and more than one in four thinks that a cure for cancer exists but is being kept from the public by a profit-driven health-care industry.
› Verified 6 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1164040069 | NPI | - | NPPES |
| 1164040069 | Medicaid | RI |
News Archive
Scratching the skin triggers a series of immune responses culminating in an increased number of activated mast cells-immune cells involved in allergic reactions-in the small intestine, according to research conducted in mice.
The Medical University of South Carolina (MUSC), one of the nation's top academic health science centers, and Alliance Oncology, a division of Alliance HealthCare Services, Inc., announce a newly formed affiliation designed to strengthen and expand MUSC's Hollings Cancer Center as the radiation therapy market leader in Charleston, South Carolina.
In the study, which appeared on the pre-print server medRxiv, the team developed a general mathematical theory to predict airborne transmission risk from carbon dioxide (CO2) time series in real-time and clarify different estimates that steer the guideline. The study findings were based on the assessment of transmission risk and implementing the guideline by CO2 monitoring in university classrooms and office spaces.
YM BioSciences Inc. has announced data from two clinical trials of nimotuzumab, its humanized monoclonal antibody that targets the epidermal growth factor receptor (EGFR). Preliminary results from the two trials which are evaluating nimotuzumab in combination with radiation therapy for the treatment of brain metastases and high-grade gliomas, conducted by YM's licensor, were presented at the 2008 EORTC-NCI-AACR annual meeting recently held in Geneva, Switzerland.
A new survey has discovered the quite astonishing fact that almost half of American adults mistakenly believe that surgery can spread cancer, and more than one in four thinks that a cure for cancer exists but is being kept from the public by a profit-driven health-care industry.
› Verified 6 days ago
Coastal Medical, Inc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 900 Warren Ave, Ste 401, East Providence, RI 02914 Phone: 401-421-4000 | |
Trident Psychological Services Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 172 Taunton Ave Ste 208, East Providence, RI 02914 Phone: 401-450-0729 Fax: 401-537-1830 | |
Eastside Neurology, Inc. Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 450 Veterans Memorial Pkwy, Building 11, East Providence, RI 02914 Phone: 401-431-1860 Fax: 401-435-0328 | |
Prestige Aba Therapy Services, Inc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 855 Waterman Ave Ste D, East Providence, RI 02914 Phone: 401-219-1351 Fax: 401-210-1850 | |
Michelle Baker Consulting, Inc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 21 Leonard Ave, East Providence, RI 02914 Phone: 401-359-6566 | |
Jeanine Le-kreuzer, Lmhc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 3421 Pawtucket Ave, East Providence, RI 02914 Phone: 401-684-0312 |